Literature DB >> 24975911

Comorbidities and differential diagnosis in heart failure with preserved ejection fraction.

Ross T Campbell1, John J V McMurray2.   

Abstract

Careful consideration must be given when diagnosing heart failure with preserved ejection fraction (HF-PEF). HF-PEF diagnosis is challenging and essentially a diagnosis of exclusion, with comorbidities potentially making the diagnosis more difficult. This article describes the comorbidities commonly associated with HF-PEF, the potential influence of these comorbidities on morbidity and mortality, and the differential diagnosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comorbidity; HF-PEF; HF-REF; Prognosis

Mesh:

Year:  2014        PMID: 24975911     DOI: 10.1016/j.hfc.2014.04.009

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  8 in total

Review 1.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2017-04-11       Impact factor: 4.132

Review 2.  Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging.

Authors:  Sadi Loai; Hai-Ling Margaret Cheng
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

3.  Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.

Authors:  Noemi Bruno; Piergiuseppe Agostoni
Journal:  Intern Emerg Med       Date:  2016-04-05       Impact factor: 3.397

Review 4.  Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?

Authors:  Sumeet S Mitter; Sanjiv J Shah
Journal:  Curr Atheroscler Rep       Date:  2015-11       Impact factor: 5.113

5.  Cognitive impairment in heart failure is associated with altered Wnt signaling in the hippocampus.

Authors:  Camilo Toledo; Claudia Lucero; David C Andrade; Hugo S Díaz; Karla G Schwarz; Katherin V Pereyra; Alexis Arce-Álvarez; Nicolás A López; Milka Martinez; Nibaldo C Inestrosa; Rodrigo Del Rio
Journal:  Aging (Albany NY)       Date:  2019-08-25       Impact factor: 5.682

6.  Loss of myeloid differentiation protein 1 promotes atrial fibrillation in heart failure with preserved ejection fraction.

Authors:  Wei Shuai; Bin Kong; Hongjie Yang; Hui Fu; He Huang
Journal:  ESC Heart Fail       Date:  2020-01-29

7.  Comorbidities, risk factors and outcomes in patients with heart failure and an ejection fraction of more than or equal to 40% in primary care- and hospital care-based outpatient clinics.

Authors:  B Eriksson; P Wändell; U Dahlström; P Näsman; L H Lund; M Edner
Journal:  Scand J Prim Health Care       Date:  2018-04-10       Impact factor: 2.581

8.  Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design.

Authors:  Ross T Campbell; Colette E Jackson; Ann Wright; Roy S Gardner; Ian Ford; Patricia M Davidson; Martin A Denvir; Karen J Hogg; Miriam J Johnson; Mark C Petrie; John J V McMurray
Journal:  ESC Heart Fail       Date:  2015-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.